D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
80,800
+3,300 (4.26%)
Feb 9, 2026, 9:18 AM KST

D&D Pharmatech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,373,996513,608----
Enterprise Value
3,342,162494,061----
Last Close Price
77500.0012150.00----
PS Ratio
403.4544.91----
PB Ratio
45.067.38----
P/TBV Ratio
75.2414.45----
EV/Sales Ratio
-43.20----
Debt / Equity Ratio
0.090.140.151.470.320.03
Asset Turnover
0.090.130.220.000.01-
Quick Ratio
8.743.202.280.471.146.63
Current Ratio
9.823.582.610.611.227.28
Return on Equity (ROE)
-47.71%-47.25%9.29%-174.72%-43.71%-38.23%
Return on Assets (ROA)
-19.54%-17.70%-9.75%-24.89%-19.70%-16.52%
Return on Invested Capital (ROIC)
-68.60%-51.56%-30.26%-108.81%-65.13%-80.88%
Return on Capital Employed (ROCE)
-34.40%-29.00%-18.80%-177.30%-41.10%-31.40%
Earnings Yield
-1.03%-5.57%----
FCF Yield
-0.72%-4.32%----
Buyback Yield / Dilution
-144.62%-8.08%-16.38%2.05%-12.66%-118.38%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.